AVXL – anavex life sciences corp. (US:NASDAQ)

News

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Anavex Life Sciences (AVXL) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $24.00 price target on the stock.
Anavex Life Sciences Provides Comprehensive Regulatory Update [Yahoo! Finance]
Anavex Life Sciences Provides Comprehensive Regulatory Update
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com